Serum-Free Suspension Adaptation of HEK-293T Cells: Basis for Large-Scale Biopharmaceutical Production

Autor(es)

Ana Luiza Oliveira Lomba ^[1] ; Mariane Cariati Tirapelle ^[2] ; Rafael Tagé Biaggio ^[3] ; Mário Soares Abreu-Neto ^[4] ; Dimas Tadeu Covas ^[5] ; Virginia Picanço-Castro ^[6] ; Kamilla Swiech ; Amanda Mizukami ^[8]

Afiliação do(s) autor(es)

^[1] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

^[2] University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto. Department of Pharmaceutical Sciences - Brasil

^[3] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

^[4] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

^[5] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

^[6] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

^[8] University of São Paulo. Ribeirão Preto Medical School. Center for Cell-based Therapy - Brasil

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Archives of Biology and Technology; v. 64, 2021-10-25.

Resumo

Abstract Human Embryonic Kidney 293T cells (HEK-293T) are the most common host for viral vector production and are also widely employed for recombinant protein production. These cells are typically cultured in monolayer (adherent culture) using culture medium containing fetal bovine serum (FBS), which impairs batch-to-batch reproducibility and scale-up. The adaptation of adherent cell culture to suspension culture in chemically defined serum-free culture medium is an attractive approach for large-scale bioprocess implementation while aiming for a Good Manufacturing Practice (GMP) compliant production process. Therefore, in the present study, our goal was to adapt HEK-293T cells to serum-free suspension culture conditions and evaluate the feasibility of adapted cells to be transfected using different plasmid vectors for recombinant protein production. Firstly, the cells were efficiently adapted to serum-free conditions by sequential adaptation (FBS-containing medium weaning). During the whole process, parameters such as cell growth, viability and doubling time were evaluated and compared to the control (adherent serum-supplemented HEK-293T cell culture). Afterwards, these cells were adapted to suspension culture by using Erlenmeyer flasks in an orbital shaker platform, being able to achieve meaningful cell density with high viability. Adapted cells presented a transfection efficiency of approximately 50% for all vector constructs used (1054-GFP, Factor-VIII and Factor-IX). Overall, it was possible to successfully adapt HEK-293T cells to suspension and serum-free conditions, which represents an important step towards the development of a scalable and GMP-compliant production process. In addition, adapted cells efficiently expressed the different transgene tested, opening up possibilities for its use in recombinant protein production. (AU)

• Processo FAPESP: 17/21737-2 - Adaptação para cultivo em suspensão e meio de cultura livre de soro fetal bovino da linhagem celular HEK-293T para produção em larga escala de vetores lentivirais
• Beneficiário: Ana Luiza Oliveira Lomba
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica
• Processo FAPESP: 13/08135-2 - CTC - Centro de Terapia Celular
• Beneficiário: Dimas Tadeu Covas
• Modalidade de apoio: Auxílio à Pesquisa - Centros de Pesquisa, Inovação e Difusão - CEPIDs